About Tirzepatide (LY3298176)
Tirzepatide is an innovative peptide that simultaneously targets GIP and GLP-1 receptors, providing significant glycemic control and weight loss. Clinical studies have demonstrated body weight reductions of up to 20–25%, making it one of the most effective options available for weight loss research.
Main Research Areas
- Significant weight loss (up to 20–25%)
- Superior glycemic control
- Reduction of appetite and hunger
- Improved insulin sensitivity
- Reduction of visceral fat
| Property |
Value |
| CAS # |
2023788-19-2 |
| Molecular Formula |
C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular Weight (M.W.) |
4813.527 g/mol |
Purity: ≥99% by HPLC | Form: Lyophilized Powder | Use: Research Use Only (RUO)
Legal Notice
This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for non-laboratory use. The information is exclusively informational in nature and should not be interpreted as medical, clinical, or legal guidance. For Research Purposes Only.